HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 3 filers reported holding HEALTH CATALYST INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,554 | +114.7% | 3,118 | +165.1% | 0.00% | – |
| Q2 2023 | $14,700 | +91775.0% | 1,176 | -13.8% | 0.00% | -100.0% |
| Q1 2023 | $16 | +23.1% | 1,364 | +13.2% | 0.00% | 0.0% |
| Q4 2022 | $13 | -100.0% | 1,205 | -79.4% | 0.00% | 0.0% |
| Q3 2022 | $57,000 | -81.9% | 5,840 | -73.1% | 0.00% | -85.7% |
| Q2 2022 | $315,000 | +775.0% | 21,732 | +1455.6% | 0.01% | – |
| Q1 2022 | $36,000 | -23.4% | 1,397 | +17.9% | 0.00% | -100.0% |
| Q4 2021 | $47,000 | -74.9% | 1,185 | -68.2% | 0.00% | -80.0% |
| Q3 2021 | $187,000 | +240.0% | 3,728 | +279.6% | 0.01% | +400.0% |
| Q2 2021 | $55,000 | -68.4% | 982 | -73.7% | 0.00% | -66.7% |
| Q1 2021 | $174,000 | +128.9% | 3,730 | +114.6% | 0.00% | +50.0% |
| Q4 2020 | $76,000 | -93.1% | 1,738 | -94.2% | 0.00% | -83.3% |
| Q3 2020 | $1,101,000 | +760.2% | 30,077 | +584.3% | 0.01% | +140.0% |
| Q2 2020 | $128,000 | +456.5% | 4,395 | +566.9% | 0.01% | +150.0% |
| Q4 2019 | $23,000 | +228.6% | 659 | +237.9% | 0.00% | – |
| Q3 2019 | $7,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 852,504 | $8,269,000 | 11.18% |
| Nepsis Inc. | 826,841 | $8,020,000 | 2.90% |
| First Light Asset Management, LLC | 1,149,833 | $11,153,000 | 1.13% |
| Bullseye Asset Management LLC | 55,434 | $538,000 | 0.31% |
| Portolan Capital Management | 303,602 | $2,945,000 | 0.31% |
| CVS HEALTH Corp | 32,273 | $313,000 | 0.30% |
| Rock Springs Capital Management LP | 880,000 | $8,536,000 | 0.22% |
| Granahan Investment Management | 648,299 | $6,289,000 | 0.20% |
| Bares Capital Management | 452,400 | $4,388,000 | 0.17% |
| Rhenman & Partners Asset Management AB | 180,000 | $1,588,000 | 0.17% |